FindTrial
Sign In

MEROPENEM 2 grams TID

DRUG2 trials

Sponsors

Johns Hopkins University, BioVersys SAS

Conditions

Acinetobacter Baumannii-calcoaceticus ComplexColistin Resistanrt ABCHospital Acquired Bacterial Pneumonia (HABP)Tuberculosis, PulmonaryVentilator Associated Bacterial Pneumonia (VABP)

Phase 2

Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB
CompletedNCT03174184
Johns Hopkins UniversityTuberculosis, Pulmonary
Start: 2017-08-23End: 2022-05-13Updated: 2023-07-19

Phase 3

Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex
Not yet recruitingNCT07326540
BioVersys SASAcinetobacter Baumannii-calcoaceticus Complex, Colistin Resistanrt ABC, Hospital Acquired Bacterial Pneumonia (HABP) +1
Start: 2026-03-20End: 2028-03-30Target: 248Updated: 2026-01-08

Related Papers

Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial
American Journal of Respiratory and Critical Care Medicine2022-03-0830 citations